stockrow
Friday 6 November 2026
Export BWIN’s income statement to Excel — free account
Baldwin Insurance Group, Inc.
BWIN Financial Insurance Brokers
Baldwin Insurance Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 8.34% from fiscal 2024.
- Revenue
- +30.1%
- EPS
- −740.0%
- Free cash flow
- +208.1%
- Total debt
- +52.7%
Quarter to June 2026, against a year earlier
31.98
0.16
−0.50%
Follow BWIN
Alert me
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | 5 | 3 | 6 | 4 | 4 | 6 | 4 |
P/E ratio |
272.83 | 272.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.00 | 0.00 | 2.09 | 3.38 | 3.03 | 1.45 | 1.17 | 1.77 | 1.08 |
P/FCF ratio |
0.00 | 0.00 | 27.93 | 25.98 | 49.37 | 0.00 | 0.00 | 236.40 | 0.00 |
P/Operating CF |
0.00 | 0.00 | (112.55) | 134.71 | 131.30 | 100.07 | (62.53) | (1,068.89) | 158.98 |
P/B ratio |
0.00 | 0.00 | 1.21 | 1.06 | 1.45 | 1.25 | 1.40 | 2.44 | 1.51 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 1.87 | 4.39 | 4.27 | 2.60 | 2.10 | 2.59 | 2.00 |
EV/EBITDA |
0.00 | 0.00 | 37.90 | 0.00 | 103.61 | 42.25 | 41.94 | 20.47 | 14.49 |
EV/Operating CF |
2.46 | 2.46 | 21.42 | 28.73 | 60.39 | (1,036.22) | 55,601.23 | 69.80 | (102.17) |
EV/FCF |
2.66 | 2.66 | 25.00 | 33.74 | 69.62 | (104.38) | (119.91) | 345.21 | (43.59) |
Quick Ratio |
0.00 | 1.13 | 1.78 | 1.37 | 1.05 | 1.09 | 0.82 | 0.96 | 1.15 |
Current Ratio |
— | 1.16 | 1.83 | 1.39 | 1.07 | 1.10 | 0.90 | 0.97 | 1.16 |
Net Debt/EBITDA |
0.00 | 5.09 | (4.52) | (316.46) | 30.14 | 18.73 | 17.84 | 6.19 | 6.39 |
Debt/Assets |
55.56% | 52.04% | 10.12% | 25.19% | 32.42% | 39.33% | 37.38% | 39.55% | 43.32% |
Debt/Equity |
(0.62) | (1.16) | 0.17 | 0.50 | 0.79 | 1.19 | 1.29 | 1.39 | 1.54 |
Asset Turnover |
0.52 | 0.86 | 0.51 | 0.25 | 0.26 | 0.31 | 0.35 | 0.39 | 0.41 |
Operating CF/Net income |
4.71 | (18.90) | (1.39) | (2.35) | (1.31) | 0.06 | 0.00 | (2.10) | 0.87 |
Capex/Depreciation |
— | (0.16) | (0.14) | (0.26) | (0.10) | (0.24) | (0.21) | (0.36) | (0.30) |
Interest Coverage |
— | 1.44 | (0.48) | (2.79) | (1.18) | (0.44) | (0.36) | 0.49 | 0.61 |
| (3.28%) | 1.21% | (9.91%) | (3.12%) | (3.13%) | (3.59%) | (8.35%) | (2.42%) | (3.23%) | |
| 1.84% | (0.68%) | (3.21%) | (1.63%) | (1.39%) | (1.32%) | (2.59%) | (0.70%) | (0.91%) | |
ROIC |
0.00% | 296.15% | (1.53%) | (1.35%) | (1.04%) | (0.86%) | (1.26%) | 1.81% | 1.92% |
Return on Tangible Assets |
170.33% | (8.30%) | (13.64%) | (16.42%) | (55.54%) | (42.37%) | 106.27% | 307.55% | (17.85%) |
Average Days of Receivables |
0.00 | 134.27 | 155.68 | 235.59 | 219.30 | 197.99 | 188.05 | 184.49 | 203.54 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.78 | 0.68 | 0.64 | 0.79 | 0.76 | 0.73 | 0.69 | 0.67 | 0.65 |
Share Based Compensation of Revenue |
0.00% | 1.75% | 2.38% | 3.21% | 3.38% | 4.83% | 4.92% | 4.72% | 4.73% |
Graham Net Nets |
0.00 | 0.00 | (0.10) | (0.56) | (0.65) | (1.09) | (1.09) | (0.61) | (0.97) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
0.37% | 0.37% | (3.24%) | (1.63%) | (1.61%) | (2.84%) | (6.30%) | (0.95%) | (2.00%) |
Free Cash Flow Yield |
0.00% | 0.00% | 3.58% | 3.85% | 2.03% | (1.72%) | (1.50%) | 0.42% | (4.22%) |
Revenue per Share |
2.55 | 4.24 | 7.69 | 8.87 | 11.92 | 17.26 | 20.26 | 21.89 | 22.15 |
Operating CF per Share |
0.43 | 0.63 | 0.67 | 1.35 | 0.84 | (0.04) | 0.00 | 0.81 | (0.43) |
Capex per Share |
0.00 | (0.03) | (0.10) | (0.20) | (0.11) | (0.39) | (0.36) | (0.65) | (0.58) |
Free Cash Flow per Share |
0.43 | 0.60 | 0.57 | 1.15 | 0.73 | (0.43) | (0.35) | 0.16 | (1.01) |
Cash per Share |
0.16 | 0.42 | 3.97 | 5.23 | 4.79 | 4.06 | 3.68 | 4.93 | 5.11 |
Shareholders Equity per Share |
(2.12) | (3.33) | 13.24 | 28.33 | 24.95 | 20.05 | 16.94 | 15.89 | 15.95 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(2.12) | (3.33) | 13.24 | 28.33 | 24.95 | 20.05 | 16.94 | 15.89 | 15.95 |
Free Cash Flow |
8.02 | 11.27 | 10.30 | 31.35 | 34.81 | (24.44) | (21.33) | 10.40 | (68.94) |
Working Capital |
— | 5.37 | 60.10 | 84.57 | 37.70 | 73.19 | (107.53) | (29.94) | 166.96 |
Capital Expenditures |
(0.43) | (0.52) | (1.72) | (5.47) | (5.32) | (21.98) | (21.38) | (41.05) | (39.53) |
Net Current Asset Value |
(39.00) | (163.99) | (28.59) | (458.05) | (1,110.63) | (1,550.23) | (1,557.54) | (1,499.90) | (1,578.62) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 59.22 | 40.65 |
Capex to Sales |
0.00 | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | 0.02 | 0.03 | 0.03 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 40.55 | 22.08 |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.00 | 1.49 | 3.57 | 1.92 | 3.15 | 3.60 | 4.56 | 5.22 | 5.93 |
Cash ROIC |
(66.80%) | 62.60% | 2.95% | 2.42% | 1.48% | (0.89%) | (0.84%) | 0.38% | (2.22%) |
Accounts Receivable Turnover |
0.00 | 1.81 | 3.13 | 2.25 | 2.29 | 2.25 | 2.10 | 2.09 | 1.95 |
Accounts Payable Turnover |
0.00 | 3.59 | 2.28 | 1.60 | 1.56 | 1.64 | 1.59 | 1.55 | 1.42 |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 191.86 | 218.39 | 335.07 | 321.05 | 266.46 | 248.26 | 252.66 | 266.25 |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | 44.09 | 44.09 | 107.15 | 248.17 | 436.41 | 579.89 | 664.94 | 770.63 |
Average Payables |
14.40 | 14.40 | 42.58 | 108.92 | 255.86 | 438.55 | 572.55 | 667.13 | 742.79 |
Average Assets |
92.50 | 92.41 | 269.30 | 964.34 | 2,203.11 | 3,169.24 | 3,482.06 | 3,518.33 | 3,698.48 |
Average Common Equity |
(52.00) | (51.38) | 87.25 | 503.56 | 978.58 | 1,163.42 | 1,079.02 | 1,013.42 | 1,046.11 |
Columns are period end dates